Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
Risk of fractures in patients with multiple sclerosis: record-linkage study.
[An update on the treatment options for multiple sclerosis].
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.
A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
Pediatric Multiple Sclerosis-A Challenging Demyelinating Disease: Case Report and Brief Review of the Literature.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
Vitamin D insufficiency and chronic diseases: Hype and reality.
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Clinical use of brain volumetry.
[Effects of caffeine citrate on myelin basic protein in neonatal rats with hypoxic-ischemic brain damage].
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Multiple sclerosis in Syria.
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »